NCT02539108 Safety and Immunogenicity of the 2015-2016 Formulation of Fluzone® Quadrivalent (Influenza Vaccine) Among Healthy Children Status COMPLETED Phase PHASE4
NCT02529904 ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and Adults Status COMPLETED Phase PHASE2
NCT02525055 Characterisation of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model Status COMPLETED Phase NA
NCT02522754 Development of an Intranasal Proteosome Influenza Vaccine Status COMPLETED Phase PHASE1/PHASE2
NCT02485639 Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination Status TERMINATED Phase PHASE4
NCT02480101 Reactogenicity, Safety and Immunogenicity of a LAIV H7N9 Influenza Vaccine Status COMPLETED Phase PHASE1
NCT02473510 Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season Status COMPLETED Phase PHASE4
NCT02467842 Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly Subjects Status COMPLETED Phase PHASE3
NCT02464163 Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older Status COMPLETED Phase PHASE1/PHASE2
NCT02459171 Household Transmission of Zoonotic Influenza Viruses in a Cohort of Egyptian Poultry Growers Status COMPLETED Phase N/A
NCT02451358 Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India Status COMPLETED Phase PHASE3
NCT02438423 Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle Status COMPLETED Phase PHASE1
NCT02434276 Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years Status UNKNOWN Phase PHASE2
NCT02423577 Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain Status COMPLETED Phase PHASE2
NCT02385123 Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers Status TERMINATED Phase PHASE4
NCT02381418 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season Status COMPLETED Phase PHASE3
NCT02369341 Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above Status COMPLETED Phase PHASE3